Enteric Coated Myfortic for Liver Transplant Recipients

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Liver Transplantation
Interventions
DRUG

Myfortic

720 mg by mouth every 12 hours

Trial Locations (1)

77030

Memorial Hermann Hospital, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER